Skip to main content
Cost-effectiveness of treatment strategies for BRAF-mutated metastatic melanoma
Published Web Location
http://europepmc.org/articles/PMC4157865?pdf=renderNo data is associated with this publication.
Abstract
© 2014 Curl et al.Purpose: Genetically-targeted therapies are both promising and costly advances in the field of oncology. Several treatments for metastatic melanoma with a mutation in the BRAF gene have been approved. They extend life but are more expensi
Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.